fbpx

Trial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients

Trial of Regeneron’s Covid-19 Antibody Drug Is Halted in Sickest Hospital Patients

Regeneron Pharmaceuticals Inc. suspended testing of its Covid-19 antibody drug in the sickest hospitalized patients because of a safety concern, the l

No Revenue, No Problem: Wall Street Rushes Into Electric Car and Truck Startups
Cheese Makers Reel as Pandemic Sows Market Chaos
General Motors Poaches Delta CFO to Fill Finance Seat

Regeneron Pharmaceuticals Inc. suspended testing of its Covid-19 antibody drug in the sickest hospitalized patients because of a safety concern, the latest setback for antibody-drug trials in patients with the most advanced disease.

Regeneron said Friday it is pausing enrollment of hospitalized Covid-19 patients receiving mechanical ventilation or high-flow oxygen, after an independent monitoring committee observed “a potential safety signal and an unfavorable risk/benefit profile at this time.”

The…

This post first appeared on wsj.com

Do You Enjoy This Article?
Sign up for our newsletter and receive FREE access to download SuccessDigest Digital Weekly Edition for attainment of your financial freedom in the new digital economy!

Invalid email address
We promise not to spam you. You can unsubscribe at any time.

COMMENTS

WORDPRESS: 0
DISQUS:
%d bloggers like this: